These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16875805)

  • 1. Cholesterol lowering and mortality: time for a new paradigm?
    de Lorgeril M; Salen P
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):387-90. PubMed ID: 16875805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol lowering, sudden cardiac death and mortality.
    de Lorgeril M; Salen P
    Scand Cardiovasc J; 2008 Aug; 42(4):264-7. PubMed ID: 18615354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol lowering and mortality: a great success story!
    Trevisan M; Stranges S
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):391-4. PubMed ID: 16875804
    [No Abstract]   [Full Text] [Related]  

  • 4. Lowering cholesterol levels in patients with coronary heart disease. The LIPID Study Management Committee.
    Med J Aust; 1995 May; 162(9):455-6. PubMed ID: 7746199
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipid-altering therapies on ventricular arrhythmias and sudden cardiac death.
    Majmudar MD; Tompkins C; Bachmann JM; Blumenthal RS; Marine JE
    Cardiol Rev; 2009; 17(2):60-9. PubMed ID: 19367147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol and cardiac arrhythmias.
    Goonasekara CL; Balse E; Hatem S; Steele DF; Fedida D
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):965-79. PubMed ID: 20602558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
    Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterol synthesis inhibitors: lowering of cholesterol for everybody?].
    Westendorp RG; Smelt AH
    Ned Tijdschr Geneeskd; 1996 Feb; 140(8):411-4. PubMed ID: 8720812
    [No Abstract]   [Full Text] [Related]  

  • 12. [Optimal lipid lowering therapy for coronary heart diseases patients in secondary prevention: moderate or aggressive LDL decrease preferred?].
    MMW Fortschr Med; 2006 Nov; 148(48):54-5. PubMed ID: 17615773
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
    de Lau LM; Stricker BH; Breteler MM
    Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac effects of statins--advancements and open questions.
    Laufs U; Böhm M
    Cardiovasc Res; 2005 Jun; 66(3):427-9. PubMed ID: 15914106
    [No Abstract]   [Full Text] [Related]  

  • 15. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and treatment of coronary heart disease. The importance of cholesterol synthesis enzyme inhibition].
    Kostner K
    Pharm Unserer Zeit; 2003; 32(6):480-7. PubMed ID: 14639829
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic coronary disease in the post-COURAGE Era: a new paradigm.
    Fass AE
    Cardiol Rev; 2010; 18(6):292-7. PubMed ID: 20926938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of interventions aiming at reducing sudden cardiac death in dialysis patients.
    de Bie MK; van Dam B; Gaasbeek A; van Buren M; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
    Eur Heart J; 2009 Jul; 30(13):1559-64. PubMed ID: 19465437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention].
    Thomas HP; Kassner U; Steinhagen-Thiessen E
    MMW Fortschr Med; 2000 Jul; 142(30):33-4. PubMed ID: 10955017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.